MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • MDS Virtual Congress 2020

    Cardiac Autonomic Dysfunction in Patients with Multiple System Atrophy: A cross-sectional study

    G. Ganagarajan, T.N Sathyaprabha, K. Udupa, M.R Raghurama, K. Kuravatti, B.S Prasad, R. Yadav, K. Kambhampati, P. John (Bangalore, India)

    Objective: The study aimed to assess cardiac autonomic dysfunction in patients with multiple system atrophy (MSA). Background: MSA is a progressive neurodegenerative disorder with predominant…
  • MDS Virtual Congress 2020

    Laryngeal movement disorders as a potential clinical biomarker in multiple system atrophy: Results from the LaPD study

    F. Gandor, A. Vogel, I. Claus, S. Ahring, D. Gruber, H.J Heinze, R. Dziewas, G. Ebersbach, T. Warnecke (Beelitz-Heilstätten, Germany)

    Objective: To systematically assess frequency and nature of laryngeal dysfunction in multiples system atrophy (MSA) compared to Parkinson’s disease (PD) and to identify a potential…
  • MDS Virtual Congress 2020

    Body Weight-Supported Treadmill Training Improves Walking Function in Multiple System Atrophy: A Case Report

    R. Hand, C. Testa (Richmond, VA, USA)

    Objective: Multiple system atrophy (MSA) is a rapidly progressive synucleinopathy involving autonomic dysfunction and impaired mobility. MSA has been further sub-classified into two phenotypes: parkinsonian…
  • MDS Virtual Congress 2020

    Sleep-related Symptoms in Multiple System Atrophy: Determinants and Impact on disease severity

    J.Y Lin, L.Y Zhang, B. Cao, QQ. Wei, H.F Shang (Chengdu, China)

    Objective: To investigate the prevalence and determinants of sleep-related symptoms in multiple system atrophy (MSA) and the impact of sleep disturbances on disease severity. Background:…
  • MDS Virtual Congress 2020

    Towards a scoring system to distinguish early parkinsonian variant of multiple system atrophy from Parkinson’s disease

    P. Millar Vernetti, J.A Palma, L. Norcliffe-Kaufmann, M. Pérez, A. Fanciulli, F. Krismer, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, M.J Martí, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, G. Wenning, H. Kaufmann (New York, NY, USA)

    Objective: To develop a clinical score to distinguish between the parkinsonian variant of multiple system atrophy (MSA-P) and Parkinson’s disease (PD). Background: The differential diagnosis…
  • MDS Virtual Congress 2020

    Disease stage and UMSARS progression: Implications for clinical trials

    M. Pérez, J.A Palma, L. Norcliffe-Kaufmann, P. Millar Vernetti, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, D. Giraldo, M.J Martí, A. Fanciulli, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, F. Krismer, G. Wenning, H. Kaufmann (New York, NY, USA)

    Objective: To study the rate of progression of multiple system atrophy (MSA) and assess for a potential ceiling effect of the Unified Multiple System Atrophy…
  • MDS Virtual Congress 2020

    Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy

    Y. Saitoh, M. Miyazaki, A. Tsuru, Y. Takahashi (Kodaira, Tokyo, Japan)

    Objective: To investigate whether REM sleep without atonia (RWA) is associated with sleep architecture in patients with multiple system atrophy (MSA). Background: In MSA patients,…
  • MDS Virtual Congress 2020

    Treatment of Neurogenic Orthostatic Hypotension (nOH) in Multiple System Atrophy (MSA) with a wearable Pneumatic Compression Garment utilising Soft Robotics

    N. Sawal, H. Singh, A. Beri (Chandigarh, India)

    Objective: To use a novel Pneumatic Garment device for treatment of nOH in MSA. Background: nOH is present in 66-90% of patients with MSA and…
  • MDS Virtual Congress 2020

    Atypical Psychogenic Nonepileptic Seizure (PNES) preceding Multiple System Atrophy (MSA)

    A. Shahinian, T. Mehta, A. Betcher, P. Janda, J. Mahajan, A. Vickers (Las Vegas, NV, USA)

    Objective: To share a case report of Atypical PNES and MSA. Background: Multiple system atrophy (MSA) is a rare neurodegenerative diagnosis that clinically presents with…
  • MDS Virtual Congress 2020

    Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy

    C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)

    Objective: This study aimed to characterize the cognitive profiles of multiple system atrophy (MSA) and explore the possible mechanisms involved using 18F-fluorodeoxyglucose (FDG) Positron Emission…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley